ACSM3: Acyl-CoA Synthetase Medium-Chain Family Member 3

Key enzyme in mitochondrial fatty acid metabolism and potential biomarker in metabolic disorders

Gene Information Card

Symbol ACSM3
Full Name acyl-CoA synthetase medium-chain family member 3
Gene Type protein-coding
Chromosomal Location 16p13.11
NCBI Gene ID 6296 ncbi.nlm.nih.gov/gene/6296
Ensembl ID ENSG00000103197
UniProt ID Q53FZ2
OMIM ID 614359
HGNC ID 24125
Aliases SAH, MGC150433, MGC150434

Description

ACSM3 (acyl-CoA synthetase medium-chain family member 3) encodes a mitochondrial enzyme that catalyzes the ATP-dependent activation of medium-chain fatty acids (C4-C12) to their corresponding acyl-CoA thioesters. This reaction is the first step in mitochondrial fatty acid beta-oxidation. The enzyme also exhibits activity towards salicylate and other aromatic carboxylates. ACSM3 is expressed in liver, kidney, and heart, and its dysregulation has been implicated in metabolic disorders and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) - modifier ACSM3 may influence metabolic flux in fatty acid oxidation; variants could modulate disease severity PMID: 23463024
Hepatocellular carcinoma Downregulation of ACSM3 in tumor tissue; potential tumor suppressor role via altered lipid metabolism PMID: 28723890
Colorectal cancer Hypermethylation of ACSM3 promoter leading to reduced expression; associated with poor prognosis PMID: 30108163

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Kidney 8.3 Medium
Heart 6.1 Medium
Skeletal muscle 3.2 Low
Brain 1.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 15.2 High expression
HEK293 (embryonic kidney) 9.8 Moderate expression
HeLa (cervical) 2.4 Low expression
A549 (lung) 1.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Likely loss of start codon; predicted loss of function
c.104C>T (p.Thr35Met) missense <0.01% Rare variant; functional impact uncertain
c.487G>A (p.Gly163Arg) missense <0.01% Located in AMP-binding domain; may reduce catalytic activity
Mutation functional classification

Loss of Function (LOF)

Rare missense variants in the AMP-binding domain (e.g., p.Gly163Arg) are predicted to impair enzyme activity, reducing medium-chain fatty acid activation.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ACSM3.

Dominant Negative (DN)

No dominant-negative mutations have been described for ACSM3.

Gene Ontology (GO)

• GO:0003987 - acetate-CoA ligase activity • GO:0005524 - ATP binding
• GO:0005739 - mitochondrion • GO:0006635 - fatty acid beta-oxidation
• GO:0016874 - ligase activity

Pathways

Fatty acid metabolism (Reactome: R-HSA-8978868)
Beta-oxidation of medium-chain fatty acids (KEGG: map00071)

Protein Summary

ACSM3 is a 576-amino acid mitochondrial protein belonging to the acyl-CoA synthetase family. It contains an AMP-binding domain and a CoA-binding domain. The enzyme activates medium-chain fatty acids (C4-C12) and salicylate, playing a critical role in mitochondrial beta-oxidation. Structural studies indicate a homodimeric organization. Post-translational modifications include N-terminal acetylation and phosphorylation at Ser-123.

Related Products

Product name Cat.No. Species Gene ID
ACSM3 Knockout HEK293 Cell Line EDJ-KQ5711 Human 6296 Details Get a Quote
ACSM3 Knockout A-549 Cell Line EDJ-KQ29087 Human 6296 Details Get a Quote
ACSM3 Knockout HCT 116 Cell Line EDJ-KQ27831 Human 6296 Details Get a Quote
ACSM3 Knockout HeLa Cell Line EDJ-KQ54389 Human 6296 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: